Annual CFF
-$4.81 B
+$4.31 B+47.25%
31 December 2023
Summary:
Merck & Co annual cash flow from financing activities is currently -$4.81 billion, with the most recent change of +$4.31 billion (+47.25%) on 31 December 2023. During the last 3 years, it has fallen by -$1.98 billion (-69.84%). MRK annual CFF is now -285.50% below its all-time high of $2.59 billion, reached on 31 December 2021.MRK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$2.42 B
-$3.64 B-299.42%
30 September 2024
Summary:
Merck & Co quarterly cash flow from financing activities is currently -$2.42 billion, with the most recent change of -$3.64 billion (-299.42%) on 30 September 2024. Over the past year, it has increased by +$1.84 billion (+43.20%). MRK quarterly CFF is now -146.57% below its all-time high of $5.21 billion, reached on 31 December 2021.MRK Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$6.27 B
+$1.84 B+22.73%
30 September 2024
Summary:
Merck & Co TTM cash flow from financing activities is currently -$6.27 billion, with the most recent change of +$1.84 billion (+22.73%) on 30 September 2024. Over the past year, it has dropped by -$2.15 billion (-52.17%). MRK TTM CFF is now -341.73% below its all-time high of $2.59 billion, reached on 31 December 2021.MRK TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.3% | +43.2% | -52.2% |
| 3 y3 years | -69.8% | -6.6% | -404.7% |
| 5 y5 years | +63.5% | +23.1% | +49.5% |
MRK Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -285.5% | +47.3% | -146.6% | +43.2% | -341.7% | +31.3% |
| 5 y | 5 years | -285.5% | +63.5% | -146.6% | +43.2% | -341.7% | +49.5% |
| alltime | all time | -285.5% | +68.4% | -146.6% | +75.2% | -341.7% | +58.9% |
Merck & Co Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.42 B(-299.4%) | -$6.27 B(-22.7%) |
| June 2024 | - | $1.22 B(-143.2%) | -$8.11 B(+45.6%) |
| Mar 2024 | - | -$2.81 B(+25.3%) | -$5.57 B(+15.8%) |
| Dec 2023 | -$4.81 B(-47.3%) | -$2.25 B(-47.4%) | -$4.81 B(+16.8%) |
| Sept 2023 | - | -$4.27 B(-213.6%) | -$4.12 B(+61.4%) |
| June 2023 | - | $3.76 B(-283.0%) | -$2.55 B(-68.4%) |
| Mar 2023 | - | -$2.05 B(+32.2%) | -$8.09 B(-11.3%) |
| Dec 2022 | -$9.12 B(-451.7%) | -$1.55 B(-42.5%) | -$9.12 B(+286.7%) |
| Sept 2022 | - | -$2.70 B(+52.1%) | -$2.36 B(+22.2%) |
| June 2022 | - | -$1.78 B(-42.4%) | -$1.93 B(-220.2%) |
| Mar 2022 | - | -$3.09 B(-159.3%) | $1.60 B(-38.1%) |
| Dec 2021 | $2.59 B(-191.6%) | $5.21 B(-329.0%) | $2.59 B(-308.8%) |
| Sept 2021 | - | -$2.27 B(-229.4%) | -$1.24 B(-55.9%) |
| June 2021 | - | $1.76 B(-183.8%) | -$2.82 B(-18.1%) |
| Mar 2021 | - | -$2.10 B(-252.9%) | -$3.44 B(+21.5%) |
| Dec 2020 | -$2.83 B(-68.0%) | $1.37 B(-135.6%) | -$2.83 B(-54.4%) |
| Sept 2020 | - | -$3.85 B(-438.7%) | -$6.21 B(+12.7%) |
| June 2020 | - | $1.14 B(-176.3%) | -$5.52 B(-36.9%) |
| Mar 2020 | - | -$1.49 B(-25.9%) | -$8.74 B(-1.4%) |
| Dec 2019 | -$8.86 B(-32.7%) | -$2.01 B(-36.2%) | -$8.86 B(-28.6%) |
| Sept 2019 | - | -$3.15 B(+51.2%) | -$12.42 B(+11.2%) |
| June 2019 | - | -$2.08 B(+29.1%) | -$11.17 B(-7.3%) |
| Mar 2019 | - | -$1.61 B(-71.0%) | -$12.05 B(-8.4%) |
| Dec 2018 | -$13.16 B(+31.5%) | -$5.57 B(+192.2%) | -$13.16 B(-1.6%) |
| Sept 2018 | - | -$1.91 B(-35.8%) | -$13.38 B(+22.3%) |
| June 2018 | - | -$2.97 B(+9.0%) | -$10.94 B(-22.9%) |
| Mar 2018 | - | -$2.72 B(-52.9%) | -$14.19 B(+41.8%) |
| Dec 2017 | -$10.01 B(+10.6%) | -$5.79 B(-1179.3%) | -$10.01 B(+61.4%) |
| Sept 2017 | - | $536.00 M(-108.6%) | -$6.20 B(-18.1%) |
| June 2017 | - | -$6.22 B(-525.6%) | -$7.57 B(+60.5%) |
| Mar 2017 | - | $1.46 B(-173.9%) | -$4.72 B(-47.8%) |
| Dec 2016 | -$9.04 B(+67.9%) | -$1.98 B(+136.8%) | -$9.04 B(-4.5%) |
| Sept 2016 | - | -$835.00 M(-75.2%) | -$9.47 B(-15.2%) |
| June 2016 | - | -$3.37 B(+17.4%) | -$11.18 B(-16.6%) |
| Mar 2016 | - | -$2.87 B(+19.1%) | -$13.41 B(+148.9%) |
| Dec 2015 | -$5.39 B(-64.7%) | -$2.41 B(-5.2%) | -$5.39 B(-57.8%) |
| Sept 2015 | - | -$2.54 B(-54.6%) | -$12.75 B(+42.7%) |
| June 2015 | - | -$5.60 B(-208.6%) | -$8.94 B(-23.7%) |
| Mar 2015 | - | $5.16 B(-152.8%) | -$11.71 B(-23.2%) |
| Dec 2014 | -$15.24 B(+154.5%) | -$9.77 B(-864.0%) | -$15.24 B(+88.3%) |
| Sept 2014 | - | $1.28 B(-115.3%) | -$8.09 B(-34.1%) |
| June 2014 | - | -$8.37 B(-616.6%) | -$12.29 B(+316.7%) |
| Mar 2014 | - | $1.62 B(-161.7%) | -$2.95 B(-50.8%) |
| Dec 2013 | -$5.99 B(+83.3%) | -$2.62 B(-10.0%) | -$5.99 B(+30.7%) |
| Sept 2013 | - | -$2.92 B(-400.5%) | -$4.58 B(+90.4%) |
| June 2013 | - | $970.00 M(-168.3%) | -$2.41 B(-39.3%) |
| Mar 2013 | - | -$1.42 B(+16.7%) | -$3.96 B(+21.3%) |
| Dec 2012 | -$3.27 B(-52.7%) | -$1.22 B(+65.0%) | -$3.27 B(-23.7%) |
| Sept 2012 | - | -$738.00 M(+25.9%) | -$4.28 B(-26.0%) |
| June 2012 | - | -$586.00 M(-19.2%) | -$5.79 B(-10.4%) |
| Mar 2012 | - | -$725.00 M(-67.5%) | -$6.46 B(-6.5%) |
| Dec 2011 | -$6.90 B(+26.9%) | -$2.23 B(-0.6%) | -$6.90 B(+15.7%) |
| Sept 2011 | - | -$2.24 B(+78.5%) | -$5.97 B(+11.6%) |
| June 2011 | - | -$1.26 B(+7.3%) | -$5.35 B(-29.2%) |
| Mar 2011 | - | -$1.17 B(-9.5%) | -$7.55 B(+38.9%) |
| Dec 2010 | -$5.44 B(+232.2%) | -$1.29 B(-20.3%) | -$5.44 B(-9.2%) |
| Sept 2010 | - | -$1.63 B(-53.1%) | -$6.00 B(-11.1%) |
| June 2010 | - | -$3.46 B(-467.6%) | -$6.74 B(+2117.2%) |
| Mar 2010 | - | $942.00 M(-150.9%) | -$304.10 M(-81.4%) |
| Dec 2009 | -$1.64 B(-70.3%) | -$1.85 B(-22.1%) | -$1.64 B(+6.0%) |
| Sept 2009 | - | -$2.37 B(-179.7%) | -$1.54 B(-265.7%) |
| June 2009 | - | $2.98 B(-859.2%) | $932.20 M(-140.0%) |
| Mar 2009 | - | -$391.90 M(-77.7%) | -$2.33 B(-57.8%) |
| Dec 2008 | -$5.52 B(+13.5%) | -$1.76 B(-1778.7%) | -$5.52 B(+7.0%) |
| Sept 2008 | - | $104.60 M(-136.3%) | -$5.16 B(-21.0%) |
| June 2008 | - | -$288.10 M(-92.0%) | -$6.53 B(-9.7%) |
| Mar 2008 | - | -$3.58 B(+156.9%) | -$7.23 B(+48.6%) |
| Dec 2007 | -$4.87 B | -$1.40 B(+10.3%) | -$4.87 B(+25.0%) |
| Sept 2007 | - | -$1.26 B(+27.7%) | -$3.89 B(-5.8%) |
| June 2007 | - | -$990.20 M(-18.6%) | -$4.13 B(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$1.22 B(+189.3%) | -$4.60 B(-17.9%) |
| Dec 2006 | -$5.60 B(+84.3%) | -$420.40 M(-72.0%) | -$5.60 B(+1.3%) |
| Sept 2006 | - | -$1.50 B(+3.1%) | -$5.53 B(+10.7%) |
| June 2006 | - | -$1.46 B(-34.3%) | -$5.00 B(+6.3%) |
| Mar 2006 | - | -$2.22 B(+534.8%) | -$4.70 B(+54.6%) |
| Dec 2005 | -$3.04 B(-45.6%) | -$350.00 M(-63.8%) | -$3.04 B(-40.1%) |
| Sept 2005 | - | -$966.80 M(-16.8%) | -$5.08 B(-1.5%) |
| June 2005 | - | -$1.16 B(+106.9%) | -$5.15 B(-2.2%) |
| Mar 2005 | - | -$561.70 M(-76.5%) | -$5.27 B(-5.7%) |
| Dec 2004 | -$5.59 B(-18.1%) | -$2.39 B(+129.3%) | -$5.59 B(-25.8%) |
| Sept 2004 | - | -$1.04 B(-18.5%) | -$7.53 B(-10.0%) |
| June 2004 | - | -$1.28 B(+44.7%) | -$8.37 B(+5.2%) |
| Mar 2004 | - | -$883.20 M(-79.6%) | -$7.95 B(+16.5%) |
| Dec 2003 | -$6.83 B(+23.4%) | -$4.33 B(+130.6%) | -$6.83 B(+45.1%) |
| Sept 2003 | - | -$1.88 B(+117.4%) | -$4.71 B(+11.5%) |
| June 2003 | - | -$863.40 M(-457.4%) | -$4.22 B(-18.5%) |
| Mar 2003 | - | $241.60 M(-111.0%) | -$5.18 B(-6.4%) |
| Dec 2002 | -$5.53 B(+16.5%) | -$2.21 B(+58.5%) | -$5.53 B(+17.7%) |
| Sept 2002 | - | -$1.39 B(-23.6%) | -$4.70 B(-14.5%) |
| June 2002 | - | -$1.82 B(+1513.0%) | -$5.49 B(+55.6%) |
| Mar 2002 | - | -$112.90 M(-91.8%) | -$3.53 B(-25.7%) |
| Dec 2001 | -$4.75 B(+37.8%) | -$1.37 B(-37.2%) | -$4.75 B(+28.0%) |
| Sept 2001 | - | -$2.19 B(-1633.1%) | -$3.71 B(+11.9%) |
| June 2001 | - | $142.70 M(-110.7%) | -$3.31 B(-0.0%) |
| Mar 2001 | - | -$1.33 B(+299.1%) | -$3.32 B(-3.8%) |
| Dec 2000 | -$3.45 B(-10.9%) | -$333.80 M(-81.4%) | -$3.45 B(-3.9%) |
| Sept 2000 | - | -$1.79 B(-1368.9%) | -$3.59 B(+44.5%) |
| June 2000 | - | $141.20 M(-109.7%) | -$2.48 B(-44.4%) |
| Mar 2000 | - | -$1.46 B(+209.1%) | -$4.46 B(+15.4%) |
| Dec 1999 | -$3.87 B(-1.3%) | -$473.40 M(-31.0%) | -$3.87 B(-14.9%) |
| Sept 1999 | - | -$686.50 M(-62.7%) | -$4.55 B(-19.2%) |
| June 1999 | - | -$1.84 B(+112.3%) | -$5.63 B(+30.4%) |
| Mar 1999 | - | -$867.50 M(-24.8%) | -$4.31 B(+10.0%) |
| Dec 1998 | -$3.92 B(-19.3%) | -$1.15 B(-34.6%) | -$3.92 B(-9.7%) |
| Sept 1998 | - | -$1.76 B(+233.7%) | -$4.34 B(-9.4%) |
| June 1998 | - | -$528.80 M(+11.6%) | -$4.79 B(+3.1%) |
| Mar 1998 | - | -$473.90 M(-69.9%) | -$4.65 B(-4.4%) |
| Dec 1997 | -$4.86 B(+26.6%) | -$1.57 B(-29.0%) | -$4.86 B(+13.5%) |
| Sept 1997 | - | -$2.22 B(+474.8%) | -$4.28 B(+61.8%) |
| June 1997 | - | -$385.40 M(-43.8%) | -$2.65 B(-31.4%) |
| Mar 1997 | - | -$685.80 M(-31.1%) | -$3.86 B(+0.5%) |
| Dec 1996 | -$3.84 B(+173.8%) | -$994.80 M(+71.6%) | -$3.84 B(+50.3%) |
| Sept 1996 | - | -$579.80 M(-63.7%) | -$2.55 B(+16.0%) |
| June 1996 | - | -$1.60 B(+140.1%) | -$2.20 B(+85.1%) |
| Mar 1996 | - | -$665.40 M(-329.8%) | -$1.19 B(-15.2%) |
| Dec 1995 | -$1.40 B(-58.8%) | $289.60 M(-227.3%) | -$1.40 B(-57.1%) |
| Sept 1995 | - | -$227.50 M(-61.1%) | -$3.27 B(-15.8%) |
| June 1995 | - | -$585.50 M(-33.3%) | -$3.88 B(+6.9%) |
| Mar 1995 | - | -$878.00 M(-44.3%) | -$3.63 B(+6.7%) |
| Dec 1994 | -$3.40 B(+1488.3%) | -$1.58 B(+87.8%) | -$3.40 B(+404.3%) |
| Sept 1994 | - | -$839.60 M(+149.7%) | -$674.60 M(-27.9%) |
| June 1994 | - | -$336.20 M(-48.3%) | -$936.10 M(+66.1%) |
| Mar 1994 | - | -$649.70 M(-156.5%) | -$563.60 M(+163.1%) |
| Dec 1993 | -$214.20 M(-84.2%) | $1.15 B(-204.5%) | -$214.20 M(-89.6%) |
| Sept 1993 | - | -$1.10 B(-3133.3%) | -$2.06 B(+86.4%) |
| June 1993 | - | $36.30 M(-112.1%) | -$1.11 B(-15.3%) |
| Mar 1993 | - | -$300.30 M(-56.9%) | -$1.31 B(-3.7%) |
| Dec 1992 | -$1.36 B(+19.1%) | -$696.20 M(+377.8%) | -$1.36 B(+15.1%) |
| Sept 1992 | - | -$145.70 M(-10.6%) | -$1.18 B(-2.7%) |
| June 1992 | - | -$162.90 M(-53.5%) | -$1.21 B(+2.8%) |
| Mar 1992 | - | -$350.50 M(-32.4%) | -$1.18 B(+3.5%) |
| Dec 1991 | -$1.14 B(+19.3%) | -$518.60 M(+190.9%) | -$1.14 B(+28.9%) |
| Sept 1991 | - | -$178.30 M(+37.0%) | -$882.60 M(-10.6%) |
| June 1991 | - | -$130.10 M(-58.2%) | -$987.50 M(+3.6%) |
| Mar 1991 | - | -$311.10 M(+18.2%) | -$953.60 M(-0.0%) |
| Dec 1990 | -$953.70 M(-0.2%) | -$263.10 M(-7.1%) | -$953.70 M(+38.1%) |
| Sept 1990 | - | -$283.20 M(+194.4%) | -$690.60 M(+69.5%) |
| June 1990 | - | -$96.20 M(-69.1%) | -$407.40 M(+30.9%) |
| Mar 1990 | - | -$311.20 M | -$311.20 M |
| Dec 1989 | -$955.40 M | - | - |
FAQ
- What is Merck & Co annual cash flow from financing activities?
- What is the all time high annual CFF for Merck & Co?
- What is Merck & Co annual CFF year-on-year change?
- What is Merck & Co quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Merck & Co?
- What is Merck & Co quarterly CFF year-on-year change?
- What is Merck & Co TTM cash flow from financing activities?
- What is the all time high TTM CFF for Merck & Co?
- What is Merck & Co TTM CFF year-on-year change?
What is Merck & Co annual cash flow from financing activities?
The current annual CFF of MRK is -$4.81 B
What is the all time high annual CFF for Merck & Co?
Merck & Co all-time high annual cash flow from financing activities is $2.59 B
What is Merck & Co annual CFF year-on-year change?
Over the past year, MRK annual cash flow from financing activities has changed by +$4.31 B (+47.25%)
What is Merck & Co quarterly cash flow from financing activities?
The current quarterly CFF of MRK is -$2.42 B
What is the all time high quarterly CFF for Merck & Co?
Merck & Co all-time high quarterly cash flow from financing activities is $5.21 B
What is Merck & Co quarterly CFF year-on-year change?
Over the past year, MRK quarterly cash flow from financing activities has changed by +$1.84 B (+43.20%)
What is Merck & Co TTM cash flow from financing activities?
The current TTM CFF of MRK is -$6.27 B
What is the all time high TTM CFF for Merck & Co?
Merck & Co all-time high TTM cash flow from financing activities is $2.59 B
What is Merck & Co TTM CFF year-on-year change?
Over the past year, MRK TTM cash flow from financing activities has changed by -$2.15 B (-52.17%)